What Indiana Life Sciences, Inc does

Indiana Life Sciences, Inc operates as BioCrossroads, a nonprofit catalyst organization that serves as the central convening body for Indiana's life sciences industry. Founded in 1992 (with the BioCrossroads initiative active since 2002) and headquartered at 1210 Waterway Boulevard in Indianapolis, the organization operates as one of five branded initiatives under the Central Indiana Corporate Partnership (CICP). BioCrossroads does not sell commercial products; instead, it delivers a portfolio of interconnected programs and resources including the Indiana Seed Funds (I, II, and III — totaling approximately $24M in assets under management across 30+ portfolio companies), the AXIS Mentoring Program, the Odyssey Group founder community, the Career TraX platform, the Indiana Career Apprenticeship Pathway (INCAP), the annual Life Sciences Summit, the FrameWORX educational series, the BioSignals Podcast, and data tools such as the Life Sciences Dashboard and Book of Data and Organizations.

BioCrossroads' business model is sponsorship- and grant-driven rather than product-driven. Revenue is derived from CICP corporate partners (including Eli Lilly, Cook Medical, Zimmer Biomet, and Roche, whose executives sit on the Board of Directors), event sponsorships, and grant funding. The organization serves four primary stakeholder segments: life sciences companies (biotech, pharma, medical devices, diagnostics, health IT), Indiana's three R1 research universities (Indiana University, Purdue, Notre Dame), entrepreneurs and startups, and the broader workforce/talent pipeline. Its core "product" is ecosystem connectivity — facilitating partnerships, capital flows, and workforce development — rather than discrete commercial offerings.

The organization's strategic priorities are reflected in its recent moves: anchoring the radiopharmaceutical ecosystem buildout (Novartis RLT facility, Cardinal Health theranostics expansion, POINT Biopharma, Isotopia), expanding biomanufacturing workforce training through the 2025 NIBRT partnership, positioning AI as a 2026 Summit theme, and launching new venture-facing initiatives such as Crossroads Health Ventures. With approximately 1–10 employees and a deeply networked board, BioCrossroads operates as a high-leverage, low-headcount platform whose value derives from the density and quality of its institutional relationships rather than from internal scale.

Name

Indiana Life Sciences, Inc

Website

https://biocrossroads.com

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

1–10 employees

Short description

BioCrossroads is a nonprofit catalyst organization serving Indiana's life sciences industry through seed funding, entrepreneurship programs, workforce development, industry convenings, and ecosystem research for companies, universities, startups, and workforce partners.

Ownership category

akta.pro rank

Product category

Life Sciences Industry Development (Nonprofit Catalyst Services)

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)

SIC

Investment Advice (6282), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Healthcare & Life Sciences Growth Equity (FSANACAB)

akta.pro secondary industry

Pharmaceuticals & Biotechnology (EDABALAU)

Keywords

• Life sciences catalyst
• Seed capital funding
• Workforce development programs
• Industry convening services
• Executive networking programs

Headquarters

HQ city

Indianapolis

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others, Technology or R&D

Revenue model

1. Ecosystem Development and Support: As a nonprofit initiative of the Central Indiana Corporate Partnership (CICP), BioCrossroads operates as a catalyst organization. It facilitates investments in promising startups, builds new enterprises, and educates through conferences, reports, and market development knowledge. Revenue is derived from partnerships, sponsorships, and grant funding rather than product sales.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels8 records

Core offering

Indiana Life Sciences, Inc (operating as BioCrossroads) is a nonprofit industry catalyst that grows Indiana's life sciences sector by convening industry, academia, and government, providing seed-stage capital through the Indiana Seed Funds, and delivering workforce, executive, and entrepreneur programs such as AXIS, Odyssey Group, Career TraX, FrameWORX, and INCAP.

Product overview

BioCrossroads operates as a catalyst organization advancing Indiana's life sciences industry through multiple interconnected programs and resources. The portfolio includes investment vehicles (Indiana Seed Funds), workforce development programs (INCAP, Career TraX), entrepreneurial support (AXIS Mentoring Program, Odyssey Group, Startup Hub), industry events (Life Sciences Summit, FrameWORX series), and data tools (Life Sciences Dashboard, Book of Data and Organizations). The organization connects corporate, academic, and philanthropic partners while providing education through conferences, reports, and market development knowledge. BioCrossroads does not offer a single unified product but rather a suite of ecosystem-enabling programs and resources.

Differentiator

Problem solved

Functional benefit

Products and services

• Indiana Seed Funds (I, II, and III) Seed-stage investment funds that provide capital to Indiana-based life sciences startups in exchange for equity, supporting early-stage companies in biotech, diagnostics, medical devices, and agbioscience. The funds are managed by BioCrossroads as part of its role as an industry catalyst.
• AXIS Executive networking and peer engagement program that connects Indiana life sciences leaders across companies and functions for relationship-building and collaboration.
• Odyssey Group C-suite peer mentoring and leadership development program that pairs experienced life sciences executives with emerging leaders across Indiana's life sciences ecosystem.
• Career TraX Workforce development program that connects students, graduates, and job-seekers with career opportunities in Indiana's life sciences industry, often through partnerships with Indiana research universities.
• FrameWORX Statewide life sciences recruitment fair that brings together Indiana life sciences employers with student and professional job-seekers.
• INCAP Online talent and job-matching platform that connects Indiana life sciences employers with candidates across the state.
• Life Sciences Dashboard Interactive data dashboard providing industry intelligence on Indiana's life sciences sector, including employment, company, and investment metrics.
• Startup Hub Entrepreneur support program offering mentorship, workspace, and connections to Indiana life sciences founders and early-stage companies.
• Central Indiana Corporate Partnership (CICP) Coordination Industry-development coordination services delivered as an initiative of the Central Indiana Corporate Partnership (CICP), aligning Indiana life sciences corporate partners, research universities, and state government.

Quantifiable outcome

• 30+ portfolio companies raised over $500M+ in additional venture funding
• +3 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

18 partnerships are on record, tiered core, flagship and minor.

• Indiana UniversitycoreStrategic or Co-development PartnerR1 research university partner contributing cutting-edge expertise in nuclear medicine and biomedical engineering. IU School of Medicine is a major driver of life sciences research and talent pipeline in Indiana.
• Purdue UniversitycoreStrategic or Co-development PartnerR1 research university partner contributing expertise in nuclear medicine and biomedical engineering. Purdue is a key research and talent development partner for Indiana's life sciences ecosystem.
• University of Notre DamecoreStrategic or Co-development PartnerR1 research university partner contributing to the innovation ecosystem. Vice President for Research Jeff Rhoads serves on BioCrossroads Board.
• Eli Lilly and CompanyflagshipStrategic or Co-development PartnerHeadquartered in Indianapolis, Eli Lilly is Indiana's largest pharmaceutical company and a anchor tenant of the state's life sciences ecosystem. CEO Dave Ricks serves on BioCrossroads Board. Company committed $9B+ in capital investments in Indiana in 2024.
• NovartisflagshipStrategic or Co-development PartnerSwitzerland-headquartered Novartis is constructing a new radioligand therapy (RLT) manufacturing facility in Indianapolis, extending world-class manufacturing and supply chain capabilities in Indiana.
• POINT BiopharmacoreStrategic or Co-development PartnerMajor player in radiopharmaceutical production and targeted radiotherapies, anchoring Indiana's position as the Radiopharmaceutical Capital of the World.
• Isotopia Molecular ImagingcoreStrategic or Co-development PartnerPartner in radiopharmaceuticals contributing to Indiana's growing hub for production of medical isotopes and targeted radiotherapies.
• Cardinal HealthcoreStrategic or Co-development PartnerExpanded theranostics facility in Indianapolis with $50M+ investment to accelerate cancer-fighting radiopharmaceutical production.
• Indiana Biosciences Research Institute (IBRI)coreStrategic or Co-development PartnerFirst industry-inspired research institute in the nation, founded by global life science companies with mission to accelerate discoveries leading to innovations for metabolic disease and poor nutrition.
• Indiana Health Information ExchangecoreStrategic or Co-development PartnerOperates the nation's largest health information exchange, providing secure interoperable health IT network connecting 100+ hospitals, care facilities, health clinics and other healthcare providers.
• National Institute for Biopharmaceutical Training (NIBRT)coreStrategic or Co-development PartnerOfficial partnership announced at 2025 Summit to boost Indiana's biomanufacturing workforce development through specialized training programs.
• OrthoWorxcoreStrategic or Co-development PartnerCommunity-based initiative working strategically with orthopedic industry, life sciences partners, and regional stakeholders to advance the orthopedic industry (Orthopedic Capital of the World in Warsaw, Indiana).
• Cooley LLPminorStrategic or Co-development PartnerLegal partner supporting Odyssey Group founder community programming with practical tools and resources for biotech founders.
• JP MorganminorStrategic or Co-development PartnerFinancial services partner supporting Odyssey Group with founder education and network building in life sciences.
• Central Indiana Corporate Partnership (CICP)flagshipStrategic or Co-development PartnerParent organization formed in 1999 to bring together chief executives of prominent corporations, foundations, and universities. BioCrossroads is one of five CICP branded initiatives (alongside AgriNovus Indiana, Ascend Indiana, Conexus Indiana, and TechPoint).
• 16 Tech Innovation DistrictcoreStrategic or Co-development Partner50-acre community in downtown Indianapolis dedicated to world-changing innovation and economic opportunity. CICP and its branded initiatives including BioCrossroads are located at 16 Tech.
• Cook MedicalflagshipStrategic or Co-development PartnerWorld's largest privately-held medical company, headquartered in Bloomington. Chairman Dan Peterson serves as Chair of BioCrossroads Board of Directors.
• Zimmer BiometflagshipStrategic or Co-development PartnerMajor orthopedic company headquartered in Warsaw, Indiana. Vice President Kirk Bailey serves on BioCrossroads Board.

Scale indicators10 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Life Science Washington: Washington state life sciences association providing advocacy, talent, and capital-access programs — directly comparable state-level catalyst serving a major U.S. life sciences cluster.
• BioNJ: New Jersey's statewide life sciences trade association serving as a catalyst for one of the largest pharma clusters in the U.S. — directly comparable in mission and programmatic mix (advocacy, convening, workforce, capital access).
• California Life Sciences: California's statewide life sciences association (formerly BayBio/Bio) offering advocacy, capital access programs, talent initiatives, and convenings — directly comparable as a state-level catalyst with similar programmatic pillars.
• BioGenerator: St. Louis-based life sciences startup accelerator and seed investor that funds and builds companies from regional research institutions — directly comparable to BioCrossroads' Indiana Seed Funds plus AXIS/Odyssey programming model.
• MassBio: Massachusetts state-level life sciences trade and catalyst organization running member services, advocacy, workforce programs, and convenings — the closest direct parallel to BioCrossroads' role in Indiana, with a similar ecosystem-development mandate at much larger scale.
• BioEnterprise (JumpStart Health): Northeast Ohio biomedical and healthcare innovation accelerator — a regional catalyst and seed investor model that closely mirrors BioCrossroads' role in Indiana, though now operating within JumpStart Inc.
• BioFlorida: Florida's statewide life sciences industry association — comparable state-level catalyst focused on industry growth, capital access, and workforce development.

Broad incumbents

• AdvaMed: National medical device industry association — comparable convening and policy function but specialized to medical devices rather than BioCrossroads' full pharma/biotech/devices/diagnostics mandate.
• PhRMA: National pharmaceutical industry trade association — overlaps with BioCrossroads' advocacy and convening role but at much larger scale and with a pharma-only (vs. cross-subsector) focus.

Others

• FasterCures (Milken Institute): Nonprofit catalyzing patient-focused medical research and cross-sector collaboration — adjacent ecosystem-builder with overlapping mission around accelerating life-sciences innovation but operating nationally rather than within a single state.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/biocrossroads

Revenue estimate

Valuation estimate

Number of profiles

Profiles15 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Indiana Life Sciences, Inc